Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Blecher

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos One|October 31, 2017
Changing the South African national antiretroviral therapy guidelines: The role of cost modellingGesine Meyer-Rath, Leigh F Johnson, Yogan Pillay, et al.
Lancet (London, England)|October 17, 2024
Investing in the future of global healthAusten Davis, Samira Asma, Mark Blecher, et al.
Epidemics|March 8, 2022
Recalibrating the notion of modelling for policymaking during pandemicsYot Teerawattananon, Sarin Kc, Y-Ling Chi, et al.
Gates Open Research|February 12, 2021
What next after GDP-based cost-effectiveness thresholds?Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, et al.
The Lancet. Global Health|April 7, 2022
The Lancet Global Health Commission on financing primary health care: putting people at the centreKara Hanson, Nouria Brikci, Darius Erlangga, et al.
International Journal of Technology Assessment in Health Care|May 5, 2022
Health Technology Assessment in Support of National Health Insurance in South AfricaMaryke Wilkinson, Andrew Lofts Gray, Roger Wiseman, et al.
Lancet (London, England)|November 29, 2017
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd editionDean T Jamison, Ala Alwan, Charles N Mock, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos One|October 31, 2017
Changing the South African national antiretroviral therapy guidelines: The role of cost modellingGesine Meyer-Rath, Leigh F Johnson, Yogan Pillay, et al.
Lancet (London, England)|October 17, 2024
Investing in the future of global healthAusten Davis, Samira Asma, Mark Blecher, et al.
Epidemics|March 8, 2022
Recalibrating the notion of modelling for policymaking during pandemicsYot Teerawattananon, Sarin Kc, Y-Ling Chi, et al.
Gates Open Research|February 12, 2021
What next after GDP-based cost-effectiveness thresholds?Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, et al.
The Lancet. Global Health|April 7, 2022
The Lancet Global Health Commission on financing primary health care: putting people at the centreKara Hanson, Nouria Brikci, Darius Erlangga, et al.
International Journal of Technology Assessment in Health Care|May 5, 2022
Health Technology Assessment in Support of National Health Insurance in South AfricaMaryke Wilkinson, Andrew Lofts Gray, Roger Wiseman, et al.
Lancet (London, England)|November 29, 2017
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd editionDean T Jamison, Ala Alwan, Charles N Mock, et al.
Pageof 2